Amgen

YTD

ALL

Trade Amgen 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About AMGN

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K.

CEO

Robert A. Bradway

CEORobert A. Bradway

Employees

28,000

Employees28,000

Headquarters

Thousand Oaks, California

HeadquartersThousand Oaks, California

Founded

1980

Founded1980

Employees

28,000

Employees28,000

AMGN Key Statistics

Market cap

185.65B

Market cap185.65B

Price-Earnings ratio

26.65

Price-Earnings ratio26.65

Dividend yield

2.76%

Dividend yield2.76%

Average volume

2.76M

Average volume2.76M

High today

$349.23

High today$349.23

Low today

$341.82

Low today$341.82

Open price

$345.42

Open price$345.42

Volume

2.02M

Volume2.02M

52 Week high

$349.98

52 Week high$349.98

52 Week low

$261.43

52 Week low$261.43

Stock Snapshot

With a market cap of 185.65B, Amgen(AMGN) trades at $344.63. The stock has a price-to-earnings ratio of 26.65 and currently yields dividends of 2.8%.

On 2026-01-26, Amgen(AMGN) stock moved within a range of $341.82 to $349.23. With shares now at $344.63, the stock is trading +0.8% above its intraday low and -1.3% below the session's peak.

Trading activity shows a volume of 2.02M, compared to an average daily volume of 2.76M.

Over the past 52 weeks, Amgen(AMGN) stock has traded between a high of $349.98 and a low of $261.43.

AMGN News

Simply Wall St 14h

Will 340B Lawsuit Over Drug Discounts Shift Amgen's Access Strategy And Investment Narrative?

Sagebrush Health Services has filed a lawsuit in California Superior Court against Amgen Inc., alleging unlawful termination of 340B drug discounts and improper...

Simply Wall St 2d

Assessing Amgen Valuation After The New Sagebrush 340B Lawsuit

Advertisement Why the Sagebrush lawsuit matters for Amgen stock The new lawsuit from Sagebrush Health Services puts Amgen (AMGN) and its role in the 340B Drug...

Seeking Alpha 3d

Amgen snaps after six straight sessions of gains

Amgen (NASDAQ:AMGN) snapped six consecutive sessions of gains, as the company’s shares closed 0.66% lower at $344.78 on Friday. In the preceding six sessions,...

Analyst ratings

48%

of 33 ratings

Buy

45.5%

Hold

48.5%

Sell

6.1%

More AMGN News

Simply Wall St 4d

Amgen Faces 340B Lawsuit Spotlighting Drug Pricing And Investor Risks

Sagebrush Health Services has filed a lawsuit against Amgen (NasdaqGS:AMGN), accusing the company of improperly ending discounted drug sales under the federal 3...

Simply Wall St 5d

Amgen's Shareholders Will Receive A Bigger Dividend Than Last Year

Amgen Inc. ( ) has announced that it will be increasing its dividend from last year's comparable payment on the 6th of March to $2.52. This makes the dividend y...

TipRanks 6d

Amgen downgraded to Market Perform from Outperform at Bernstein

Bernstein downgraded Amgen (AMGN) to Market Perform from Outperform with an unchanged price target of $335 to reflect the firm’s view that “2026 is a waiting ye...

People also own

Based on the portfolios of people who own AMGN. This list is generated using Robinhood data, and it’s not a recommendation.

TE Connectivity

Rockwell Automation

Alnylam Pharmaceuticals

KLA

Natera

Cognex

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.